Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children
- hivtoolkit
- Jul 20, 2021
- 1 min read
Updated: Jan 28, 2022
This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal antiretroviral medicines and dosage forms become available.
Comments